Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.36 and traded as high as $0.37. Elite Pharmaceuticals shares last traded at $0.3690, with a volume of 252,282 shares.
Elite Pharmaceuticals Trading Up 1.5%
The company has a debt-to-equity ratio of 0.04, a quick ratio of 5.22 and a current ratio of 6.45. The firm has a market capitalization of $397.49 million, a PE ratio of 18.46 and a beta of 0.39. The stock’s 50-day simple moving average is $0.36 and its 200-day simple moving average is $0.40.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Read More
- Five stocks we like better than Elite Pharmaceuticals
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
